Additionally, theres not enough data to determine whether orforglipron is safe during pregnancy or breastfeeding
Xie, Resistance to the insulin and elevated level of androgen: A major cause of polycystic ovary syndrome
And as long as you continue to take the medication, maintaining that weight loss is likely
276 (Pt 2), R1545R1549 (1999)
Ongoing medical supervision can help ensure your treatment plan is safe, effective, and tailored to your goals.
Both compounds are developed by Eli Lilly, both target GLP-1 and GIP receptors, but Retatrutide adds a third receptor glucagon creating a triple agonist with superior weight loss results in clinical trials